Should You Buy Rigetti Computing Stock After Its 2,750% Gain Since 2024? Wall Street Has a Surprising Answer.

Rigetti Computing shares have surged ~2,750% since January 2024 and currently trade around $28, with a median analyst target of $40 (implying ~42% upside) based on coverage from seven analysts. The company touts vertical integration and a first multichip QPU, and expects a 1,000+ qubit system by 2027, but industry experts see fault-tolerant, commercially useful quantum machines as 1–2 decades away. Market valuation is extreme: a $9.3bn market cap and ~1,080x price-to-sales, prompting warnings that the stock could experience severe downside (possible 90%+ drawdowns) despite bullish momentum and limited analyst coverage. Investors should weigh the technology roadmap against the outsized valuation and concentrated speculative positioning.

Analysis

Market structure: Rigetti (RGTI) is a winner for retail/spec momentum traders and private suppliers to superconducting qubit fabs, but a clear loser for traditional hardware incumbents only if Rigetti achieves mass error-corrected scale (10k–1M qubits) — a 1–2 decade outcome. Vertical integration and multichip QPUs give Rigetti technical optionality, but the market is pricing near-term promise (market cap $9.3B, ~1,080x sales) not fundamentals, skewing supply/demand toward speculative inflows and high gamma/pin risk in equity and options markets. Cross-asset: a violent RGTI snap-back would press volatility (VIX up), widen credit spreads for small-cap tech, and have negligible FX/commodity impact but could increase demand for hedging in single-stock CDS and put options.

Risk assessment: Tail risks include a breakthrough in fault-tolerant error correction (positive shock), a large equity-capital raise/dilutive secondary (negative), or a manufacturing/cryogenics failure that halts node scaling (negative). Immediate (days) risk is retail-driven squeezes; short-term (weeks–months) risks are dilution and guidance misses; long-term (3–10+ years) binary outcome: commercial utility or obsolescence. Hidden dependencies: cash runway, wafer supply, and ability to scale control electronics/co-packaging are single points of failure; monitor quarterly cash burn >$100M/yr and share count growth >10%/quarter as red flags. Catalysts: quarterly results, announced funding rounds, or a peer technical milestone (e.g., IBM/Google fault-tolerance demo) within 3–18 months.

Trade implications: Direct play — size exposure small and tactical: prefer option-based shorts to manage short-squeeze gamma; buy 3–6 month RGTI put spreads rather than naked short equity. Relative value — pair long NVDA (NVDA) or SOXX and short RGTI to express “real hardware leader vs. speculative quantum” thesis over 6–12 months. Rotate capital out of speculative small-cap tech into large-cap AI/semiconductor leaders to capture safer secular growth while maintaining a 1–3% opportunistic dry powder bucket for distressed quantum equity.

Contrarian angles: Consensus underestimates dilution and time-to-usefulness; conversely it may over-penalize Rigetti if it demonstrates predictable scaling to 1k qubits by 2027 (a positive re-rate). Historical parallel: dot-com winners were rare; many 100x momentum winners collapsed when fundamentals mattered — expect similar selection. Unintended consequence: heavy shorting could trigger retail squeeze cycles; prefer limited-duration options and strict trade exits to avoid tail risk from momentum-driven rallies.

Key Decisions for Investors

• Establish a tactical bearish options hedge: buy 3–6 month RGTI put spreads equal to 1–2% of portfolio NAV (e.g., buy 30/20 put spread if strikes exist near current $28) to cap max loss while capturing >50% downside if equity falls >40% within 6 months; close if RGTI > $40 or implied vol drops >30% from entry.
• Implement a relative-value pair: over 6–12 months go long NVDA (size 2–3% NAV) and short RGTI equity (size 1–2% NAV) to capture dispersion between proven AI/semiconductor cashflows and speculative quantum premium; unwind if NVDA underperforms tech index by >10% or RGTI issues equity >10% accretive dilution.
• Set an opportunistic buy trigger: place limit orders to accumulate RGTI totaling 1–3% NAV only if share price drops ≥75% to ≤$7 (or market cap falls to ≤$2.5B) and company reports cash runway ≥24 months and quarter-over-quarter share count growth ≤5%; reject purchase if a dilutive raise is announced within prior 90 days.
• Reallocate 3–5% from small-cap speculative tech into large-cap semiconductor exposure (add NVDA or SOXX) over next 30 days to reduce idiosyncratic tail risk, while maintaining 1–2% tactical dry powder for event-driven quantum entry points (earnings, funding announcements).